
The impact of proton pump inhibitors on the pharmacokinetics of voriconazole in vitro and in vivo
Keywords: VRC; voriconazole; PPIs; proton pump inhibitors; LAN; lansoprazole; ESO; esomeprazol; OME; omeprazole; PAN; pantoprazole; ILA; ilaprazole; DDIs; drug-drug interactions; CYP; cytochrome P450; TDM; therapeutic drug monitoring; HLM; human liver microsomes; N